CODX

Co-Diagnostics, Inc. (CODX) ESG Analysis Analysis (2026)

Invetso Score: 5.6/10 — Balanced · Last Updated: 2026-09-01

Monthly Update

No material changes this month.

Environmental

Score: 5.2 (Moderate)

Co-Diagnostics’ environmental risk profile is moderate, with a low direct footprint and some positive impact through accessible diagnostics. However, limited transparency and scale constrain its ability to lead on environmental sustainability relative to larger industry peers.

Social

Score:

Co-Diagnostics demonstrates moderate social performance, with strengths in R&D investment and global health impact. However, limited workforce and community disclosure, and the company’s small scale, temper its overall social score.

Governance

Score:

Governance practices at Co-Diagnostics are moderate, with prudent financial management and active leadership. However, limited board and ESG disclosure, and ongoing operational challenges, constrain its governance standing relative to sector leaders.

Overall Score

Score:

Co-Diagnostics’ ESG profile is moderate across all pillars. The company’s low direct environmental impact, strong R&D focus, and commitment to global health are offset by limited transparency, small scale, and ongoing financial and operational challenges. While the company is positioned to deliver positive social impact through accessible diagnostics, its ESG performance remains in line with, but not ahead of, small-cap diagnostics peers.

Sources

  • Company filings (10-K, 10-Q, investor presentations)
  • Financial and market data providers
  • Public news and industry information

🔒 Go Beyond This Framework

This is one of 10 institutional-grade frameworks Invetso runs on Co-Diagnostics, Inc.. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.

Create your free account on Invetso →